statistiche ricercatore

Continente	#
NA - Nord America	1.440
AS - Asia	623
EU - Europa	387
SA - Sud America	106
OC - Oceania	21
Continente sconosciuto - Info sul continente non disponibili	15
AF - Africa	8
Totale	2.600

Nazione	#
US - Stati Uniti d'America	1.383
SG - Singapore	223
IT - Italia	101
CN - Cina	100
HK - Hong Kong	100
VN - Vietnam	85
BR - Brasile	81
SE - Svezia	61
GB - Regno Unito	57
DE - Germania	34
BD - Bangladesh	33
FI - Finlandia	32
CA - Canada	28
RU - Federazione Russa	22
MX - Messico	20
ES - Italia	17
AU - Australia	14
JP - Giappone	13
FR - Francia	12
IN - India	12
NL - Olanda	12
AR - Argentina	11
PL - Polonia	11
BG - Bulgaria	10
KR - Corea	10
ID - Indonesia	8
CO - Colombia	7
DK - Danimarca	7
NZ - Nuova Zelanda	7
TR - Turchia	7
UZ - Uzbekistan	6
IQ - Iraq	5
ZA - Sudafrica	4
EC - Ecuador	3
JO - Giordania	3
NO - Norvegia	3
PH - Filippine	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
CR - Costa Rica	2
IL - Israele	2
IR - Iran	2
JM - Giamaica	2
MY - Malesia	2
NI - Nicaragua	2
PK - Pakistan	2
SA - Arabia Saudita	2
UA - Ucraina	2
VE - Venezuela	2
BB - Barbados	1
BY - Bielorussia	1
BZ - Belize	1
CL - Cile	1
DZ - Algeria	1
EG - Egitto	1
GH - Ghana	1
IE - Irlanda	1
KW - Kuwait	1
LT - Lituania	1
MA - Marocco	1
MO - Macao, regione amministrativa speciale della Cina	1
PE - Perù	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
Totale	2.585

Nome	#
The complex relationship between female age and embryo euploidy	808
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology	259
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays	205
Progestins for pituitary suppression during ovarian stimulation for ART: A comprehensive and systematic review including meta-analyses	205
Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation	198
The predicted probability of live birth in In Vitro Fertilization varies during important stages throughout the treatment: analysis of 114,882 first cycles	195
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?	175
The interchangeability of two assays for the measurement of anti-Müllerian hormone when personalizing the dose of FSH in in-vitro fertilization cycles	164
Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone	153
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS	151
The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization	87
Totale	2.600

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	149	0	0	1	4	2	8	17	9	12	12	60	24
2022/2023	160	26	33	27	4	6	11	0	11	16	1	7	18
2023/2024	146	2	8	6	17	23	2	24	25	8	3	1	27
2024/2025	398	8	0	9	21	81	53	25	19	42	46	35	59
2025/2026	873	78	29	72	93	110	52	119	49	90	74	38	69
2026/2027	689	369	294	26	0	0	0	0	0	0	0	0	0
Totale													2.600